tiprankstipranks
Inhibrx Biosciences, Inc. (INBX)
NASDAQ:INBX
US Market

Inhibrx Biosciences Inc (INBX) Cash flow

58 Followers

Inhibrx Biosciences Inc Cash Flow

INBX's free cash flow for Q4 2025 was $-30.12M. For the 2025 fiscal year, INBX's free cash flow was decreased by $67.18M and operating cash flow was $-30.12M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -129.79M$ -194.41M$ -193.31M$ -115.30M$ -80.32M
Investing Cash Flow
$ -28.00K$ -2.60M$ -4.59M$ -686.00K$ -809.00K
Financing Cash Flow
$ 101.45M$ 71.68M$ 201.96M$ 258.55M$ 83.77M
End Cash Position
$ 124.22M$ 152.60M$ 277.92M$ 273.87M$ 131.30M
Free Cash Flow
$ -129.82M$ -197.01M$ -197.90M$ -115.99M$ -81.19M
Currency in USD

Inhibrx Biosciences Inc Cash Flow